PNEUTECH
  • Home
  • Our Impact
  • Our Team
  • Contact Us

Our Impact.

Lung cancer is the leading cause of cancer related death worldwide. Through improving lung biopsies, we help decrease the number of procedure-related complications while also facilitating the emerging field of personalized treatment for lung cancer patients.

The Problem.

​Over 100,000 percutaneous lung biopsy procedures are performed every year in the US.
A critical procedure

Percutaneous lung biopsies are a critical procedure for tumor diagnosis and personalized medicine research.
​With universal challenges

​
The standard procedure uses a straight biopsy needle and system, resulting in the ability to only achieve straight paths.
​This makes it challenging to collect adequate tissue in regions that are obstructed by ribs or blood vessels.
Resulting in significant consequences

Multiple punctures, suboptimal angle of entry, increased procedure time, among other factors, increase the risk of pneumothorax, a collapsed lung, occurring in over 20% of all patients.

Our Solution.


The TroCap

The first biopsy needle device
to enable an angled or straight path 
​to access any site in only one pass

TroCap Features.

01   Mechanically-controlled

02     CT & Ultrasound compatible

03      Straight & curved paths

04      Universal workflow integration

05      Airtight properties

Revolutionizing biopsies.

By enabling safer, high-yield lung biopsy procedures, our device has the potential
to revolutionize the lung biopsy space.
Powered by Create your own unique website with customizable templates.
  • Home
  • Our Impact
  • Our Team
  • Contact Us